Zobrazeno 1 - 10
of 477
pro vyhledávání: '"Ambrogini, P."'
Autor:
Aric Anloague, Hayley M. Sabol, Japneet Kaur, Sharmin Khan, Cody Ashby, Carolina Schinke, C. Lowry Barnes, Farah Alturkmani, Elena Ambrogini, Michael Tveden Gundesen, Thomas Lund, Anne Kristine Amstrup, Thomas Levin Andersen, Marta Diaz-delCastillo, G. David Roodman, Teresita Bellido, Jesus Delgado-Calle
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Multiple myeloma (MM) is a clonal plasma cell proliferative malignancy characterized by a debilitating bone disease. Osteolytic destruction, a hallmark of MM, is driven by increased osteoclast number and exacerbated bone resorption, primarily fueled
Externí odkaz:
https://doaj.org/article/2cc6d4c16ea547a48e641d7a171fc618
Autor:
Dasiel O. Borroto-Escuela, Emmanuell Gonzalez-Cristo, Verty Ochoa-Torres, Emilio M. Serra-Rojas, Patrizia Ambrogini, Luis E. Arroyo-García, Kjell Fuxe
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 18 (2024)
The histochemical Falck-Hillarp method for the localization of dopamine (DA), noradrenaline (NA) and serotonin in the central nervous system (CNS) of rodents was introduced in the 1960s. It supported the existence of chemical neurotransmission in the
Externí odkaz:
https://doaj.org/article/32af83f52c8340bbaf3bf0dfd93a3419
Autor:
J. Kaur, M. Adhikari, H.M. Sabol, A. Anloague, S. Khan, L. Barnes, J.B. Stambough, M. Palmieri, O. ReyesCastro, E. Ambrogini, M. Almeida, C.A. O'Brien, I. Nookaew, J. Delgado-Calle
Publikováno v:
Journal of Bone Oncology, Vol 45, Iss , Pp 100533- (2024)
Externí odkaz:
https://doaj.org/article/69d2c97ef0c54ed4a4d434063fb212ac
Autor:
Hayley M. Sabol, Cody Ashby, Manish Adhikari, Aric Anloague, Japneet Kaur, Sharmin Khan, Samrat Roy Choudhury, Carolina Schinke, Michela Palmieri, C. Lowry Barnes, Elena Ambrogini, Intawat Nookaew, Jesus Delgado-Calle
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Multiple myeloma (MM) remains incurable due to disease relapse and drug resistance. Notch signals from the tumor microenvironment (TME) confer chemoresistance, but the cellular and molecular mechanisms are not entirely understood. Using clinical and
Externí odkaz:
https://doaj.org/article/55d0084f6d04406cb89cabefa045f8c2
Publikováno v:
Frontiers in Physiology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/ab0bb140c69a4cf5a5719ab8212d7d56
Autor:
Davide Lattanzi, Marica Pagliarini, Federica Rebecchi, Fabrizio Frontalini, Patrizia Ambrogini
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e23281- (2024)
The lack of economic funds commonly represents a limiting factor in scientific research and prevents scientists from developing brilliant ideas. Indeed, a new project may involve using appropriate scientific instruments and concurrently dealing with
Externí odkaz:
https://doaj.org/article/fd049cfcfc974c32acff5c1ce2b1429b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Qiang Fu, Nancy C. Bustamante-Gomez, Humberto Reyes-Pardo, Igor Gubrij, Diana Escalona-Vargas, Jeff D. Thostenson, Michela Palmieri, Joseph J. Goellner, Intawat Nookaew, C. Lowry Barnes, Jeffrey B. Stambough, Elena Ambrogini, Charles A. O’Brien
Publikováno v:
JCI Insight, Vol 8, Iss 18 (2023)
Denosumab is an anti-RANKL Ab that potently suppresses bone resorption, increases bone mass, and reduces fracture risk. Discontinuation of denosumab causes rapid rebound bone resorption and bone loss, but the molecular mechanisms are unclear. We gene
Externí odkaz:
https://doaj.org/article/82f9bbc937414ac8a33804dad0b78c04
Autor:
E.B. Zarur, S.H. Rodrigues, O. Ambrogini Jr, M.L.G. Ferraz, G. Mastroianni-Kirsztajn, L.E.C. Andrade, A.W.S. de Souza
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 56 (2023)
The indirect immunofluorescence (IIF) technique for antineutrophil cytoplasmic antibodies (ANCA) detection is subject to substantial differences across laboratories. This study aimed to assess the impact of improvements in the IIF-ANCA technique on t
Externí odkaz:
https://doaj.org/article/68587672b3394e6995110c73182235fe
Autor:
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, Aderson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo, Liliana Andrade Chebli, Erika Ruback Bertges, Antonio José Tiburcio Alves Junior, Orlando Ambrogini Junior, Bianca Loyo Pona Schiavetti da Silva, Marcio Lubini, Mauro Bafutto, Cristina Flores, Eduardo Garcia Vilela, Sandra Felice Boratto, Newton Luiz Tricarico Gasparetti Junior, Flavio Steinwurz, Nayara Salgado Carvalho, Omar Féres, José Joaquim Ribeiro da Rocha
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background The effectiveness of ustekinumab (UST) in the treatment of Crohn’s disease (CD) has been demonstrated in the pivotal Phase 3 UNITI 1 and 2 and IM-UNITI studies in both anti-TNF-naïve and anti-TNF-exposed patients. Given the sel
Externí odkaz:
https://doaj.org/article/1ae676670dde47428b23d064b72c8265